Infertility Devices Market to Inspire a Growth up to US$ 14.6 Billion by 2027 – Global Trends, Size, Share Investment, Growth Rate, Latest Technology and Regional Forecast to 2027

Global Infertility Devices Market, by Product Type (Accessories and Equipment), by Procedure (Artificial Insemination, Assisted Reproductive Technology, Fertility Surgery, and Others), by Gender (Female and Male), by End User (Hospitals & Surgical Clinics, Fertility Centers, Cryobanks, and Others), and by Region (Latin America, Europe, Asia Pacific, North America, Africa, and Middle East), In 2018, the market was worth US$ 7,104.1 million, and it is predicted to grow at an annual rate of 8.4% over the projected period (2019-2027).

Request to view Sample Report: https://www.coherentmarketinsights.com/insight/request-pdf/2579

Leading players are adopting business growth strategy such as collaborations and partnerships, propelling market growth. For example, Carl Zeiss Meditec AG partnered with Kyoto University in October 2019 to expand the company's research and development capacity. Similarly, Invo Bioscience stated in November 2019 that it had signed commercialization agreements in Turkey and Jordan for the InvoCell in-vivo fertility technology, paving the way for the company's development throughout the Middle East.

The rising incidence of infertility is likely to fuel the growth of the infertility devices market. In 2018, the global prevalence of infertility was 10-15 percent, according to the International Journal of Women's Health and Reproduction Sciences. Couples in Iran suffering from primary and secondary reproductive difficulties were at 78.4 percent and 21.6 percent, respectively, in 2018, according to the same data source.

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2579

Moreover, increasing government funding programs for infertility is further expected to drive the infertility devices market growth over the forecast period. For instance, in December 2015, Ontario (Canada) government launched the Ontario Fertility Program to provide funds to help infertile patients to overcome such infertility problems. Moreover, access to funded fertility services was available for all forms of infertility (including medical and non-medical infertility), regardless of gender, sexual orientation, or family status.

Because of the implementation of growth strategies such as product launches, investments, and facility expansion by market players to increase their market presence, North America is likely to have a dominating position in the infertility devices market over the forecast period. INVO Bioscience, Inc., a medical device business, reported in November 2015 that the US Food and Drug Administration (FDA) has approved the company's De Novo request for INVOcell. INVOcell is the first intravaginal culture system to receive FDA approval in the United States.

Furthermore, market players in North America are projected to employ inorganic expansion methods such as distribution agreements, collaborations, and acquisitions, which are projected to support the infertility devices market growth during the forecast period. In November 2018, Ferring Pharmaceuticals signed an agreement with INVO Bioscience Inc. to obtain the exclusive U.S. commercialization rights for the INVOcell intravaginal culture (IVC) system. The INVOcell IVC device, retention device, and holding block are all part of the system.

Read Press Release: https://www.coherentmarketinsights.com/press-release/infertility-devices-market-to-surpass-us-22-billion-by-2026-1358

Furthermore, due to favorable reimbursement policies by governments for infertility treatment, Europe is likely to have considerable development in the infertility devices market during the forecast period. In France, for example, according to the European Policy Audit on Fertility (EPAF) standards, women under the age of 43 receive 100 percent coverage for four IVF treatments and up to six IUI sessions.

Key Takeaways:

Due to increased adoption of partnerships and acquisition tactics by market participants, as well as increased product approvals by regulatory organizations, the worldwide infertility devices market is estimated to grow at a CAGR of 8.4 percent over the forecast period. For example, INVO Bioscience, Inc., a medical device business focusing on developing alternative treatments for people diagnosed with infertility, announced in October 2019 that their INVOcell culture and retention device had received the CE mark.

Due to increased research and innovation in the field of fertility by research institutes, the equipment sector held a prominent position in the infertility devices market in 2018. For example, a device called Spartan was developed by Worcester Polytechnic Institute researchers in 2018. By selecting faster and healthier sperm, the Spartan gadget helps women get pregnant with fewer treatment trials in IVF fertilization. Simple Periodic Array for Trapping and Isolation is the abbreviated form of Spartan. This gadget creates an array of obstacles for sperm to navigate over on their way to the outlet by using a field of three-dimensional posts. The fastest and healthiest sperm that make it through the outlet are employed in IVF (in vitro fertilization) procedures.

Due to increased innovation and development in ART, the Assisted Reproductive Technology (ART) technique sector had a leading position in the infertility devices market in 2018. For example, Esco Medical Group introduced the Semi-Closed Environment (SCE) IVF equipment in 2017 to provide a regulated environment when handling gametes and embryos during IVF procedures.

Because of the increased occurrence of infertility, the females segment dominated the infertility devices market in 2018. According to the National Survey of Family Growth (NSFG) data published in 2018, around 5.5 percent of all females in the United States were infertile, with 6.7 percent of married women aged 15 to 44 years infertile.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/infertility-devices-market-2579

Table of Content

Global Infertility Devices Market Research Report
Section 1: Global Infertility Devices Industry Overview
Section 2: Global Economic Impact on Infertility Devices Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Infertility Devices Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Infertility Devices Market Forecast

Other Exclusive Reports:

Global Injectable Drug Delivery Market – Market Insights - https://www.pharmiweb.com/press-release/2021-06-15/injectable-drug-delivery-market-safer-simpler-smarter-devices-market-value-to-worth-over-us-325-billion-at-83-cagr-by-2027

Global Pharmaceutical Packaging Equipment Market – Industry Insights - https://www.pharmiweb.com/press-release/2021-06-15/pharmaceutical-packaging-equipment-market-the-benefits-of-automation-in-pharmaceutical-manufacturing-industry-predict-a-long-term-growth-at-82-ca

Global RFID in Healthcare Market Analysis - https://www.pharmiweb.com/press-release/2021-06-15/rfid-in-healthcare-rfid-applications-and-adoptions-in-healthcare-market-size-worth-us-16-7566-mn-196-cagr-by-2027

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

This release was published on openPR.